Basic Study
Copyright ©The Author(s) 2021.
World J Gastrointest Oncol. Aug 15, 2021; 13(8): 879-892
Published online Aug 15, 2021. doi: 10.4251/wjgo.v13.i8.879
Figure 1
Figure 1 Enzyme-linked immunosorbent assay determined preoperative and postoperative plasma MMP-2 levels of colorectal cancer patients. MMP-2 levels are expressed as mean ± SD [preoperative (Preop) vs post-operative day (POD) 1 (n = 87, aP < 0.001); Preop vs POD 3 (n = 80, aP < 0.001); Preop vs POD 7-13(n = 65, aP < 0.001); Preop vs POD 14 -20 (n = 25, aP < 0.001); Preop vs POD 21-27(n = 17, aP < 0.001); POD 28-34 time point (n = 15, aP < 0.001)]. Statistical significance is expressed as aP < 0.001. POD: Post-operative day; Preop: Preoperative.
Figure 2
Figure 2 Enzyme-linked immunosorbent assay determined preoperative and postoperative plasma MMP-7 levels of colorectal cancer patients. MMP-7 levels are expressed as mean ± SD. [preoperative (Preop) vs post-operative day (POD) 1 (n = 87); Preop vs POD 3 (n = 80); Preop vs POD 7-13 (n = 65; bP < 0.001); Preop vs POD 14-20 (n = 25, bP < 0.001); Preop vs POD 21-27(n-17, cP = 0.002); POD 28-34 time point (n = 15, bP < 0.001). Statistical significance is expressed as bP < 0.001, cP < 0.01. POD: Post-operative day; Preop: Preoperative.